Carregant...
A Novel Gene Underlies Bleomycin-Response Variation in Caenorhabditis elegans
Bleomycin is a powerful chemotherapeutic drug used to treat a variety of cancers. However, individual patients vary in their responses to bleomycin. The identification of genetic differences that underlie this response variation could improve treatment outcomes by tailoring bleomycin dosages to each...
Guardat en:
| Publicat a: | Genetics |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Genetics Society of America
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6707474/ https://ncbi.nlm.nih.gov/pubmed/31171655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1534/genetics.119.302286 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|